FRFFF
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN
$18.13
0.00%
No data for this timeframe.
Vol
SEC Reports7
Recent Activity
Jun 8, 2026
SEC
Fairfax Financial Holdings completed a private offering of US$750,000,000 in 6.200% senior notes due 2056, with net proc
6-K — Impact 4/10
Jun 8, 2026
SEC
Fairfax Financial converted $150M principal of Orla Mining convertible notes into 26.6M common shares at C$7.90/share, i
6-K — Impact 6/10
Jun 5, 2026
SEC
Fairfax Financial Holdings filed an early warning report disclosing a 19.9% stake in Blue Ant Media (TSX: BAMI) after it
6-K — Impact 3/10
Analyst Ratings
1Strong Buy
7Buy
4Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
7 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 3.9/10.
NEUTRAL
6-K
4/10
Fairfax Financial Holdings completed a private offering of US$750,000,000 in 6.200% senior notes due
Jun 8, 2026
BULLISH
6-K
6/10
Fairfax Financial converted $150M principal of Orla Mining convertible notes into 26.6M common share
Jun 8, 2026
NEUTRAL
6-K
3/10
Fairfax Financial Holdings filed an early warning report disclosing a 19.9% stake in Blue Ant Media
Jun 5, 2026
NEUTRAL
6-K
2/10
Fairfax Financial Holdings declared a routine quarterly dividend of $0.315313 per share on its Serie
Jun 1, 2026
BULLISH
6-K
6/10
Fairfax completed the sale of 67,618,981 common shares of Poseidon Corp. (the holding company for Se
May 29, 2026
NEUTRAL
6-K
3/10
Fairfax Financial Holdings announced the early redemption of all C$450 million principal amount of i
Apr 29, 2026
NEUTRAL
6-K
3/10
Fairfax Financial Holdings announced details for its hybrid annual shareholders' meeting on April 16
Apr 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 67% buy across 12 analysts — 1 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $40.0B | — | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $42.0B | 5.1% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 7 | 4 | 0 | 0 | 67% | |
| May 1, 2026 | 1 | 7 | 3 | 0 | 0 | 73% | |
| Apr 1, 2026 | 1 | 7 | 3 | 0 | 0 | 73% | |
| Mar 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Feb 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Jan 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.